CGI PHARMACEUTICALS
Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and al... lergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.
CGI PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.cgipharma.com
Total Employee:
11+
Status:
Closed
Contact:
(203) 315-1222
Email Addresses:
[email protected]
Total Funding:
44.3 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Zoom Video Conferencing Zoom Proofpoint
Current Advisors List
Current Employees Featured
Founder
Investors List
Lilly Ventures
Lilly Ventures investment in Series C - CGI Pharmaceuticals
Connecticut Innovations
Connecticut Innovations investment in Series C - CGI Pharmaceuticals
Vector Fund Management
Vector Fund Management investment in Series C - CGI Pharmaceuticals
MPM Capital
MPM Capital investment in Series C - CGI Pharmaceuticals
Coastview Capital
Coastview Capital investment in Series C - CGI Pharmaceuticals
Flagship Pioneering
Flagship Pioneering investment in Series C - CGI Pharmaceuticals
Emerging Technology Partners
Emerging Technology Partners investment in Series C - CGI Pharmaceuticals
More informations about "CGI Pharmaceuticals"
CGI Pharmaceuticals - Crunchbase Company Profile
Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and …See details»
CIG PHARMA
At CIG PHARMA, we pride ourselves on our extensive expertise and continuous pursuit of innovation. Our dedicated team of scientists, veterinarians, and researchers work tirelessly to …See details»
CGI Pharmaceuticals, Inc. | LinkedIn
CGI Pharmaceuticals, Inc. | 1,659 followers on LinkedIn. CGI Pharmaceuticals was a venture-backed kinase drug discovery company. Founded out of Yale University in 2000, CGI was acquired by Gilead ...See details»
CGI Pharmaceuticals - Flagship Pioneering
CGI Pharmaceuticals, founded in 2001, was a development-stage company dedicated to the discovery and development of breakthrough small molecule kinase inhibitors for a broad range …See details»
CGI Pharmaceuticals - 2025 Company Profile - Tracxn
Mar 6, 2025 CGI Pharmaceuticals - Small molecule therapeutics for multiple oncology and immunology-based indications. Acquired by Gilead. Raised a total funding of $44.3M over 2 …See details»
About us – CIG PHARMA
Capital International Group began with the United Global for Distribution Company (Sub-distributors) which continues to operate till to day. During this period, we have successfully …See details»
CGI Pharmaceuticals - Products, Competitors, Financials, …
CGI Pharmaceuticals is a private, development-stage pharmaceutical company that has leveraged its small-molecule chemistry and kinase biology expertise to discover and develop a …See details»
CGI Pharmaceuticals - Ownership and Business Overview - Mergr
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010.The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by …See details»
CGI Pharmaceuticals - PitchBook
CGI Pharmaceuticals General Information Description. Developer of small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug …See details»
CGI Pharmaceuticals (Acquired by Gilead Sciences)
"CGI Pharmaceuticals was a development-stage pharmaceutical company that has leveraged its small molecule chemistry and kinase biology expertise to discover and develop an innovative …See details»
Gilead to buy CGI Pharm for $120M - Fierce Biotech
Jun 25, 2010 Gilead Sciences will pay up to $120 million to purchase Branford, CT-based CGI Pharmaceuticals, a private developer focused on small molecule chemistry and kinase …See details»
Gilead Sciences to Acquire CGI Pharmaceuticals for up to 120 Million
Jun 25, 2010 - Deal to Broaden Gilead's Research Expertise into Kinase Biology and Chemistry - FOSTER CITY, Calif. & BRANFORD, Conn., Jun 25, 2010 (BUSINESS WIRE) --Gilead …See details»
Global United for Distribution – CIG PHARMA
The 1 st step of our group began 2012 as (Sub-distributors) and continues to operate until this day.. During this period, we were successfully recognized as one of the top sub-distributors for …See details»
CGI Pharmaceuticals CEO, Founder, Key Executive Team, Board of ...
Explore {CGI Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
CGI and Körber announce global partnership to enable ... - CGI.com
Jan 22, 2024 CGI (NYSE: GIB) (TSX: GIB.A), one of the largest business and IT consulting companies in the world, today announced a partnership with Körber aimed at enabling …See details»
News Room – CIG PHARMA
Indication : 1 – Antiviral agent as AI, ND, IB and ILT. 2 – Antimicrobial agent 3 – Immunostimulant 4 – Growth promoter for improvement of feedSee details»
Regulatory services - CGI.com
Your organization must relinquish traditional operations for a more fit-for-purpose digitized model. This means leveraging the right digital infrastructure and tools to deliver strategic imperatives …See details»
CGI and Körber announce global partnership to enable ... - Newswire
Jan 22, 2024 Organization Profile. CGI inc. Also from this source. Volkswagen Group and CGI deepen global collaboration . CGI DigiOps, an AI-powered solution, recognized for excellence …See details»
Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 …
Jun 25, 2010 - Deal to Broaden Gilead’s Research Expertise into Kinase Biology and Chemistry - FOSTER CITY, Calif. & BRANFORD, Conn.--(BUSINESS WIRE)-- Gilead Sciences, Inc. …See details»
Gilead Sciences Buys CGI Pharma for US$120 Mil.
Jun 28, 2010 Gilead Sciences (U.S.) has entered into a definitive agreement with the privately held development-stage pharma firm, CGI Pharma (U.S.), for a total consideration of US$120 …See details»